Author

P. Fadda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

G. Nigita· 2 shared A. Canella· 1 shared A. Haffey· 1 shared A. Lagana· 1 shared C. M. Croce· 1 shared C. Schmitt· 1 shared D. Thomas· 1 shared E. R. Mardis· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. Nigita

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetically modified IL-2 bone marrow-derived myeloid cells reprogram the glioma immunosuppressive tumormicroenvironment

A. Canella, M. Nazzaro, S. Rajendran, C. Schmitt, A. Haffey, G. Nigita, D. Thomas, H. Wrightnour, P. Fadda, E. R. Mardis, T. P. Cripe, P. Rajappa

This study shows that genetically modified myeloid cells releasing IL-2 can reprogram the glioma tumor microenvironment to enhance anti-tumor immunity in a mouse model.

bioRxiv · Oct 19, 2022 · PreprintCancer Biology

A concurrent canonical and modified miRNAome pan-cancer study on TCGA and TARGET cohorts leads to an enhanced resolution in cancer

R. Distefano, L. Tomasello, G. L. R. Vinciguerra, P. Gasparini, Y. Xiang, M. Bagnoli, G. P. Marceca, P. Fadda, A. Lagana, M. Acunzo, Q. Ma, G. Nigita, C. M. Croce

The paper analyzes miRNA modifications in cancer using TCGA and TARGET datasets, showing improved clustering and prognostic insights from combining canonical and modified miRNAs.

bioRxiv · May 18, 2021 · PreprintCancer Biology